MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Neoleukin Therapeutics P/CF Ratio 2011-2026 | NLTX
Annual P/CF Ratio Neoleukin Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -0.0334 | -0.711 | -2.99 | -25.5 | -19.5 | -1.67 | -6.74 | -10.8 | -6.53 | -5.13 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0334 | -25.5 | -7.96 |
P/CF Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
0.157 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-0.0374 | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
17.2 | $ 5.6 | -2.1 % | $ 83.2 M | USA |
 |
HEXO Corp.
HEXO
|
-2.36 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-2.17 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-1.75 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-0.923 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.694 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-3.28 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-0.135 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-7.12 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
28.5 | $ 2.76 | -1.08 % | $ 1.06 B | Canada |
 |
Athenex
ATNX
|
-7.84 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
44.1 | $ 36.92 | 10.33 % | $ 1.36 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-15.3 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
40.5 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
6.7 | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
-32.7 | $ 2.52 | 1.41 % | $ 319 M | USA |
 |
Canopy Growth Corporation
CGC
|
-0.857 | $ 1.02 | - | $ 110 M | Canada |
 |
Pacira BioSciences
PCRX
|
6.22 | $ 23.61 | 1.72 % | $ 1.09 B | USA |
 |
Solid Biosciences
SLDB
|
-3.99 | $ 6.51 | -0.99 % | $ 570 M | USA |
 |
Aurora Cannabis
ACB
|
14 | $ 3.34 | -1.18 % | $ 183 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-41.6 | $ 1.09 | -1.8 % | $ 1.35 M | USA |
 |
Jupiter Wellness
JUPW
|
-1.59 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
0.647 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
38.9 | $ 1.09 | 0.46 % | $ 104 M | Canada |
 |
Tilray
TLRY
|
151 | $ 5.16 | -0.1 % | $ 3.19 B | Canada |
 |
Evolus
EOLS
|
-6.42 | $ 6.75 | 0.75 % | $ 435 M | USA |
 |
Sundial Growers
SNDL
|
-0.00572 | $ 1.46 | -0.34 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
2.65 | $ 8.19 | 3.02 % | $ 438 M | USA |
 |
cbdMD
YCBD
|
-2.47 | $ 0.7 | -1.77 % | $ 2.82 M | USA |
 |
Veru
VERU
|
-2.83 | $ 3.06 | -1.45 % | $ 44.8 M | USA |
 |
Assertio Holdings
ASRT
|
-2.67 | $ 23.48 | 0.09 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
4.57 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-17.5 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
1.45 | $ 5.22 | 0.87 % | $ 1.94 B | Canada |
 |
PetIQ
PETQ
|
6.4 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-5.39 | $ 6.49 | 3.51 % | $ 256 M | USA |
 |
Recro Pharma
REPH
|
-133 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-0.622 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-7.18 | $ 4.23 | -2.98 % | $ 211 M | USA |
 |
PLx Pharma
PLXP
|
-3.72 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
6.34 | $ 15.93 | -1.7 % | $ 18.5 B | USA |
 |
Zomedica Corp.
ZOM
|
-8.59 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-0.815 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-51.3 | $ 0.67 | -2.75 % | $ 24.1 M | USA |
 |
Tricida
TCDA
|
-2.91 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
18.5 | $ 0.76 | 5.54 % | $ 3.26 M |  China |
 |
TherapeuticsMD
TXMD
|
-2.79 | $ 1.9 | 1.06 % | $ 22 M | USA |